| GPRO 1.5587 77.89% | LIDR 1.485 29.13% | RITR 0.092899 0.98% | FLYE 1.9501 43.39% | RZLV 2.325 -19.55% | HKPD 0.3533 6.00% | NIO 4.115 -2.72% | BIAF 6.6978 46.88% | AIM 0.2474 9.47% | NVDA 217.5972 -1.44% | TSLL 9.46 -5.12% | SOXL 102.8 -8.86% | NVD 4.0499 3.05% | NCPL 0.7943 11.00% | TQQQ 69.4786 -3.39% | INTC 86.4988 -3.36% | SOXS 53.44 9.02% | SSM 3.99 48.88% | SPCX 143.81 0.08% | GYGY 1.39 16.81% | PCG 13.245 -0.19% | IBIT 44.315 -0.79% | AUUD 0.9947 0.76% | SQQQ 39.81 3.38% | AMBR 1.0699 -7.77% | FRVO 18.975 23.37% | AAPL 325.3629 2.69% | ZEO 0.2132 -10.31% | NOK 9.775 -3.60% | BITO 10.535 -0.89% | SGOV 100.4 -0.29% | ONDS 7.185 -6.15% | TSLA 358.63 -2.53% | PFE 28.805 1.21% | PLUG 2.125 -1.62% | VVOS 0.1718 -12.35% | OPEN 3.1212 -2.46% | SOFI 17.525 -1.99% | WETO 6.205 13.23% | BMNR 24.16 -4.58% | IREN 35.5885 -4.11% | TLT 82.2886 -0.28% | BTG 5.345 -2.46% | NU 14.845 2.03% | HOOD 105.3 0.47% | XLE 64.25 0.45% | AMZN 254.59 -1.99% | GDX 97.7 -0.82% | HYG 79.295 -0.65% | FNGR 0.2157 -3.27%

Insider Selling at Arteris, Inc. (NASDAQ:AIP) Raises Questions

Arteris, Inc. (NASDAQ:AIP) operates in the semiconductor industry, providing network-on-chip (NoC) interconnect IP solutions. These solutions are crucial for the design and development of complex system-on-chip (SoC) architectures. Arteris competes with other semiconductor companies that offer similar IP solutions, such as Synopsys and Cadence Design Systems.

On March 4, 2026, Raza Saiyed Atiq, a director at Arteris, executed a sale of 3,690 shares of the company's common stock at approximately $17.02 per share. This transaction follows a series of sales by Raza, including a significant sale of 73,610 shares on February 26th at an average price of $17.14 per share, totaling around $1.26 million. These sales have reduced Raza's holdings in the company by 12.58%.

Despite these sales, Raza still holds a substantial number of shares, with 390,000 shares remaining after the March 4th transaction. Prior to this, Raza had 511,483 shares valued at approximately $8.77 million. The recent sales reflect a strategic reduction in Raza's position, possibly influenced by the company's current financial metrics.

Arteris' stock opened at $16.99 following these transactions, showing a 1.3% decrease. The stock has fluctuated between a 12-month low of $5.46 and a high of $17.14. The company's financial metrics reveal challenges, with a negative price-to-earnings (P/E) ratio of -20.71, indicating negative earnings. The price-to-sales ratio is 10.60, and the enterprise value to sales ratio is 10.25, suggesting a high valuation relative to sales.

The company's financial health is further highlighted by a negative earnings yield of -4.83% and a debt-to-equity ratio of -0.62, indicating more equity than debt, which is unusual and may suggest negative equity. The current ratio of 1.13 suggests a reasonable level of short-term liquidity, with current assets slightly exceeding current liabilities. These metrics provide insight into the company's financial position amidst the recent insider selling activity.

Published on: March 5, 2026